Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia
Cornelius F. Waller(University of Freiburg), Christopher Blakeley, Eduardo J. Pennella(Mylan (United States)), Miguel H. Bronchud(Hospital Universitario Dexeus), O. Berzoy, Олександр Войтко(Kyiv City Clinical Oncology Center), Hryhoriy Adamchuk, Z. Zautashvili(Institute of Clinical Research), Y. Vinnyk, Gia Nemsadze, Giorgi Dzagnidze, Yaroslav Shparyk, Iryna Lytvyn, Andriy Rusyn, V. Popov(Medical University of Varna), István Láng(National Institute of Oncology), Rajiv Sharma(Mylan (United Kingdom)), Mark Baczkowski(Mylan (United States)), Mudgal Kothekar(Biocon (India)), Abhijit Barve(Mylan (United States))
Cited by 5Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis